.Merck beats profits requirements, increases purchases expectation on powerful need for leading drugs like Keytruda CNBCMerck & Co. (MRK US) Trumps Income Projections as Keytruda Sales Rise BloombergMerck Inventory: Pharma Giant Posts Solid Outcomes, However Expectation Falls Short Client's Business DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck defeats profit as well as sales requirements surrounded by Keytruda asset, however provides mixed full-year outlook MarketWatch.